A red double-decker bus travelling beneath the Christmas lights in central London. (Photo by JUSTIN TALLIS/AFP via Getty Images)
BRITISH regulators on Wednesday (22) approved Pfizer’s Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time as Omicron surged.
The developments came after the government said it was cutting the isolation period required for positive cases while Wales and Northern Ireland followed Scotland in unveiling new post-Christmas curbs, primarily around hospitality and large events.
Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) said it had approved a new lower-dose formulation of the Pfizer-BioNTech shot after finding it was “safe and effective” for children aged five to 11.
MHRA chief executive June Raine said there was “robust evidence to support a positive benefit risk for children in this age group”.
The “overwhelming majority” of reported side-effects from the two-shot “age-appropriate” jab related to mild symptoms, such as a sore arm or a flu-like illness, she added.
The Joint Committee on Vaccination and Immunisation, which advises UK health departments on immunisation, said it was now recommending a primary course of the vaccination be offered to some within the age group.